|  | Amyloid positive | Amyloid Negative | P* value |
---|---|---|---|---|
- Total patient, no (%) | Â | 15(6.8) | 205(93.2) | - |
- Age, yrs, mean ± SD |  | 55.2 ± 12(32–75) | 51.6 ± 13.2 (22–80) | NS |
- Male: Female, no | Â | 3:12 | 50: 155 | NS |
- Age at disease onset yrs. Mean ± SD |  | 46.07 ± 7.33 (27–65) | 40.18 ± 6.39 (17–70) | NS |
- Disease duration, yrs, Mean ± SD |  | 9.13 ± 4.67 (5–20) | 11.41 ± 6.85 (5–39) | NS |
- Constipation no (%) | Â | 7(46.6) | 39(19) | <0.019 |
- Proteinuria, no. (%) | Â | 9(60) | 17(8.3) | <0.001 |
- RF. Positive, no. (%) | Â | 10(66) | 130(63.7) | NS |
- CRP, *No, (%) | Â | 13(86) | 156(67) | NS |
- Receiving DMARD, no, (%) | Â | 12(80) | 155(75.6) | NS |
- Past use of gold, no (%) | Â | 0 | 17(8.3) | NS |
Functional class | Class 3 No (%) | 7 | 49 | < 0.5 |
 | Class 4 No (%) | 2 | 4 |  |